Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition

Authors:

Abstract
The molecular mechanism of breast and/or ovarian cancer susceptibility remains unclear in the majority of patients. While germline mutations in the regulatory non-coding regions of BRCA1 and BRCA2 genes have been described, screening has generally been limited to coding regions. The aim of this study was to evaluate the contribution of BRCA1/2 non-coding variants.
Funding Information
  • CEST Curie –This work was supported by French National Cancer Institute (INCa) (PRT-K14-134 to E. SdS)

This publication has 39 references indexed in Scilit: